IonQ receives green light from NVIDIA CEO
IonQ, Inc. $IONQ is one of the few all-American companies in the quantum computing hardware space and has made a name for itself in the tech world. Earlier this year, the company was frequently in the news with Jim Cramer, especially after Google announced that their quantum computer had outperformed a classical supercomputer. This announcement gave the sector a big boost, but Cramer remained skeptical, citing concerns from NVIDIA CEO Jensen Huang, who said the technology was not yet mature. The surprising turnaround came in May, when IonQ shares jumped 22% after Huang declared that his company could become the "NVIDIA" of quantum computing. Cramer encouraged investors to follow quant stocks closely, but also warned of IonQ's high valuation and described the stock as speculative.
Eli Lilly's broad pharmaceutical offering is convincing
In the USA and globally, Eli Lilly and Company $LLY (+0,8 %) is a leading company in the development and marketing of pharmaceuticals. The product portfolio ranges from insulin preparations for the treatment of diabetes to innovative therapies for cancer, rheumatoid arthritis and many other diseases. With well-known brands such as Humalog and Trulicity, Eli Lilly is not only focusing on the American market, but is also expanding successfully in Europe, China and Japan. Strategic partnerships to develop novel therapies have positioned Eli Lilly as one of the most important players in the pharmaceutical sector in recent years. Founded in 1876 and headquartered in Indianapolis, Indiana, the company remains true to its mission of delivering high-quality medicines and improving the lives of patients worldwide.
Sources:
https://finance.yahoo.com/news/ionq-inc-ionq-nvidia-ceo-154317690.html
https://finance.yahoo.com/quote/LLY/